Sheaff Brock Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,649
| Closed | -$207K | – | 579 |
|
|
2021
Q3 | $207K | Hold |
1,649
| – | – | 0.02% | 477 |
|
|
2021
Q2 | $223K | Sell |
1,649
-150
| -8% | -$20.3K | 0.02% | 438 |
|
|
2021
Q1 | $244K | Sell |
1,799
-233
| -11% | -$31.6K | 0.02% | 392 |
|
|
2020
Q4 | $286K | Sell |
2,032
-50
| -2% | -$7.04K | 0.02% | 338 |
|
|
2020
Q3 | $232K | Buy |
2,082
+20
| +1% | +$2.23K | 0.02% | 354 |
|
|
2020
Q2 | $231K | Buy |
+2,062
| New | +$231K | 0.02% | 348 |
|
|
2019
Q3 | – | Sell |
-2,587
| Closed | -$227K | – | 489 |
|
|
2019
Q2 | $227K | Sell |
2,587
-23
| -0.9% | -$2.02K | 0.02% | 389 |
|
|
2019
Q1 | $236K | Buy |
+2,610
| New | +$236K | 0.03% | 397 |
|
|
2018
Q4 | – | Sell |
-3,494
| Closed | -$335K | – | 521 |
|
|
2018
Q3 | $335K | Buy |
3,494
+432
| +14% | +$41.4K | 0.03% | 330 |
|
|
2018
Q2 | $291K | Buy |
3,062
+1
| +0% | +$95 | 0.03% | 354 |
|
|
2018
Q1 | $269K | Buy |
3,061
+110
| +4% | +$9.67K | 0.03% | 364 |
|
|
2017
Q4 | $250K | Sell |
2,951
-395
| -12% | -$33.5K | 0.03% | 392 |
|
|
2017
Q3 | $290K | Buy |
+3,346
| New | +$290K | 0.04% | 366 |
|
|
2017
Q1 | – | Sell |
-3,611
| Closed | -$214K | – | 642 |
|
|
2016
Q4 | $214K | Buy |
3,611
+351
| +11% | +$20.8K | 0.03% | 496 |
|
|
2016
Q3 | $216K | Sell |
3,260
-450
| -12% | -$29.8K | 0.03% | 451 |
|
|
2016
Q2 | $201K | Buy |
+3,710
| New | +$201K | 0.03% | 485 |
|
|
2016
Q1 | – | Sell |
-3,610
| Closed | -$253K | – | 694 |
|
|
2015
Q4 | $253K | Buy |
+3,610
| New | +$253K | 0.03% | 459 |
|